Literature DB >> 27094399

Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Ali Shidfar1, Tolulope Fatokun1, David Ivancic1, Robert T Chatterton2,3,4,5, Seema A Khan6,7,8, Jun Wang9,10.   

Abstract

The local endocrine environment of the breast may have stronger relations to breast cancer risk than systemic hormones. Nipple aspiration fluid (NAF) provides a window into this milieu. We hypothesized that the correlations between proteins and steroid hormones in NAF are stronger, and specific relationships may reveal links to breast cancer risk. NAF and blood samples were obtained simultaneously from 54 healthy women and from the contralateral unaffected breast of 60 breast cancer patients. The abundance of five proteins, superoxide dismutase (SOD1), C-reactive protein (CRP), chitinase-3-like protein 1 (YKL40), cathepsin D (CatD), and basic fibroblast growth factor (bFGF) in NAF was measured using ELISA. The NAF and serum concentrations of estradiol, estrone, progesterone, androstenedione, testosterone, and dehydroepiandrostrerone (DHEA) were measured using ELISA or RIA. The correlations between proteins and hormones revealed that NAF proteins correlated with each other: SOD1 with CRP (R = 0.276, P = 0.033) and CatD (R = 0.340, P = 0.0036), and bFGF with CRP (R = 0.343, P = 0.0021). NAF proteins displayed significant correlations with NAF steroids, but not with serum steroids: SOD1 with DHEA (R = 0.333, P = 0.019), YKL40 with testosterone (R = 0.389, P = 0.0012), and bFGF negatively correlated with testosterone (R = -0.339, P = 0.015). The regulation of YKL40 and bFGF by testosterone was confirmed in breast cancer cell lines. In summary, NAF proteins were more strongly related to local hormone levels than to systematic hormone levels. Some proteins were specifically correlated with different NAF steroids, suggesting that these steroids may contribute to breast cancer risk through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27094399     DOI: 10.1007/s12672-016-0264-3

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  50 in total

1.  Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.

Authors:  J F Dorgan; F Z Stanczyk; C Longcope; H E Stephenson; L Chang; R Miller; C Franz; R T Falk; L Kahle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-03       Impact factor: 4.254

2.  Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution.

Authors:  Ashok K Mohanty; Garima Singh; Murugan Paramasivam; Kolandaivelu Saravanan; Talat Jabeen; Sujata Sharma; Savita Yadav; Punit Kaur; Pravindra Kumar; Alagiri Srinivasan; Tej P Singh
Journal:  J Biol Chem       Date:  2003-01-14       Impact factor: 5.157

Review 3.  The local hormonal environment and related biomarkers in the normal breast.

Authors:  S A Khan; D Bhandare; R T Chatterton
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

4.  Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.

Authors:  P Gann; R Chatterton; K Vogelsong; J Dupuis; A Ellman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-06       Impact factor: 4.254

5.  Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Rudolf Kaaks; Franco Berrino; Timothy Key; Sabina Rinaldi; Laure Dossus; Carine Biessy; Giorgio Secreto; Pilar Amiano; Sheila Bingham; Heiner Boeing; H Bas Bueno de Mesquita; Jenny Chang-Claude; Françoise Clavel-Chapelon; Agnès Fournier; Carla H van Gils; Carlos A Gonzalez; Aurelio Barricarte Gurrea; Elena Critselis; Kay Tee Khaw; Vittorio Krogh; Petra H Lahmann; Gabriele Nagel; Anja Olsen; N Charlotte Onland-Moret; Kim Overvad; Domenico Palli; Salvatore Panico; Petra Peeters; J Ramón Quirós; Andrew Roddam; Anne Thiebaut; Anne Tjønneland; Ma Dolores Chirlaque; Antonia Trichopoulou; Dimitrios Trichopoulos; Rosario Tumino; Paolo Vineis; Teresa Norat; Pietro Ferrari; Nadia Slimani; Elio Riboli
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

6.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Authors:  Stacey A Missmer; A Heather Eliassen; Robert L Barbieri; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

7.  Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry.

Authors:  Timothy M Pawlik; Herbert Fritsche; Kevin R Coombes; Lianchun Xiao; Savitri Krishnamurthy; Kelly K Hunt; Lajos Pusztai; Jeng-Neng Chen; Charlotte H Clarke; Banu Arun; Mien-Chie Hung; Henry M Kuerer
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

8.  Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations.

Authors:  Robert T Chatterton; Seema A Khan; Richard Heinz; David Ivancic; Oukseub Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

9.  Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease.

Authors:  Wenyi Qin; Weizhu Zhu; Colette Wagner-Mann; Edward R Sauter
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

10.  Androgens induce divergent proliferative responses in human breast cancer cell lines.

Authors:  S N Birrell; J M Bentel; T E Hickey; C Ricciardelli; M A Weger; D J Horsfall; W D Tilley
Journal:  J Steroid Biochem Mol Biol       Date:  1995-05       Impact factor: 4.292

View more
  4 in total

Review 1.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

Review 2.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

3.  Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.

Authors:  Sadr-Ul Shaheed; Catherine Tait; Kyriacos Kyriacou; Joanne Mullarkey; Wayne Burrill; Laurence H Patterson; Richard Linforth; Mohamed Salhab; Chris W Sutton
Journal:  Proteomics Clin Appl       Date:  2017-06-26       Impact factor: 3.494

4.  HPLC fractionation with immunoassay of steroids from nipple aspirate fluid.

Authors:  Richard E Heinz; Robert T Chatterton
Journal:  MethodsX       Date:  2022-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.